|
 Reports of this serious neurological illness was also at the heart
of trial halts https://www.reuters.com/article/us-health-coronavirus-astrazeneca-usa-idUSKBN2782KF
in the early stages of development for both AstraZeneca and J&J's
shots, which are based on similar technology.
Giving updates on the safety of all coronavirus shots, the European
Medicines Agency (EMA) said it was assessing reports of a rare blood
condition known as capillary leak syndrome (CLS) following
inoculation with Moderna's vaccine.
The EMA said it had recorded six cases of CLS and was assessing all
data, but it was not yet clear if there was a causal association
between the reports and the vaccine.
In CLS, fluids leak from the smallest blood vessels causing swelling
and a drop in blood pressure. The condition has also been studied
with vaccines from AstraZeneca and J&J.
[to top of second column] |
 The EMA said there was
currently not enough evidence of a possible link
between rare cases of multisystem inflammatory
syndrome (MIS) and mRNA-based vaccines from
Moderna and Pfizer-BioNTech vaccine.
The regulator is reviewing if approved
coronavirus vaccines could cause MIS. The
syndrome is a serious but rare condition in
which different body parts become inflamed,
including the heart, lungs, kidneys, brain,
skin, eyes, or gastrointestinal organs.
J&J and Moderna did not immediately respond to
requests for comments.
(Reporting by Pushkala Aripaka in Bengaluru;
additional reporting by Aby Jose Koilparambil;
Editing by Arun Koyyur)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
